COVID-19: First patient to receive plasma therapy in UP dies of heart attack

The doctor, who was on a ventilator for the last 14 days, died on Saturday evening following a heart attack, KGMU Vice-Chancellor M L B Bhatt said.

Published: 09th May 2020 08:33 PM  |   Last Updated: 09th May 2020 08:33 PM   |  A+A-

A recovered COVID-19 patient who has passed his 14-day quarantine, donates plasma in the city's blood center in Wuhan in central China's Hubei province.

Representational image (EPS | Sunish P Surendran)


LUCKNOW: The first patient to receive plasma therapy as an experimental treatment for coronavirus infection in Uttar Pradesh died following a heart attack on Saturday.

The patient, a 58-year-old doctor, was admitted at the King George's Medical University (KGMU) here.

The doctor, who was on a ventilator for the last 14 days, died on Saturday evening following a heart attack, KGMU Vice-Chancellor M L B Bhatt said.

Since he had high blood pressure and diabetes, he was under the continuous observation of doctors in the isolation ward, Bhatt said.

"The patient was in a stable condition. His lungs had improved, but he later developed a urinary tract infection. Two reports of his samples came out as negative (for COVID-19) today," the vice-chancellor said.

"He, however, suffered a heart attack around 5 pm. Despite all efforts, he could not be saved," he said.

The doctor from Orai in Uttar Pradesh was administered plasma therapy at the state-run KGMU on April 26. He was administered the plasma donated by a doctor from Canada who was the first COVID-19 patient admitted at the hospital and later recovered.

Tulika Chandra of Blood Transfusion Department, KGMU said, "When the patient was given plasma therapy, his condition was very bad. His lungs, however, improved. But as he was an old patient with diabetes, he was kept on the ventilator."

Convalescent Plasma Therapy is an experimental procedure for treating COVID-19 patients.

In this treatment, plasma, a blood component, from a cured patient is transfused to a critically ill coronavirus patient.

The blood of a person who has recovered from COVID-19 develops antibodies to fight the virus.

This therapy uses the antibodies from the blood of a cured patient to treat another critical patient.

The Union health ministry, however, had advised against considering the therapy to be the regular treatment for coronavirus, adding it should be used for research and trial purposes till there is robust scientific evidence to support its efficacy.

Stay up to date on all the latest Nation news with The New Indian Express App. Download now


Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on are those of the comment writers alone. They do not represent the views or opinions of or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. reserves the right to take any or all comments down at any time.

  • Kushwaha jyoti

    How many corona patient are saved with this plasma therapy ? Only in india.
    16 days ago reply
flipboard facebook twitter whatsapp